She added that the consistency of the decreased likelihood of dementia diagnosis across the different medications was particularly noteworthy. Past studies have reported associations between GLP-1 receptor agonists and dementia, with some suggesting a reduced dementia risk after starting the medication and others indicating variability depending on how these medications cross the blood-brain barrier, Bartlet and colleagues wrote
Food and Drug Administration (FDA) issued a quarterly report (PDF) on adverse drug events on January 2, covering the period of July through September of 2023
Gene Ontology (GO) analysis indicated that EVs were enriched in proteins related to signal transduction, environmental adaptation, and transmembrane transport, while CDVs showed enrichment in ribosomal and nucleic acid metabolism-related proteins
: ,
Eli Lilly targets FDA approval for weight loss medication Drugmaker Eli Lilly is looking for FDA approval of its obesity medication after recent trial results showed positive results for weight loss
PlexusDx combines compounded GLP-1 access with biomarker insights to help you and your provider set realistic expectations tailored to your unique metabolic profile
